jueves, 18 de enero de 2018

Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole

A recent systematic literature and meta-analysis reported relative efficacy of trimethoprim-sulfamethoxazole (TMP-SMX) for the treatment of toxoplasmic encephalitis (TE) in HIV-infected adults. Here, we estimated relapse rates during secondary prophylaxis with TMP-SMX, and further explored differences in relapse rates prior to introduction of highly active antiretroviral therapy (HAART) and the widespread adoption of HAART... read more


AUTOR :
Connolly, Mark P.Haitsma, GertruudHernández, Adrián V. ( 0000-0002-9999-4003 )  Vidal, José E.
EDITORIAL :
Taylor and Francis Ltd.
REVISTA:
Pathogens and Global Health

URL: http://hdl.handle.net/10757/622484
FULL TEXT: https://goo.gl/9v8KuR



Molecular etiological profile of atypical bacterial pathogens, viruses and coinfections among infants and children with community acquired pneumonia admitted to a national hospital in Lima, Peru



Objective: The main objective of this study was to detect the presence of 14 respiratory viruses and atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae), via polymerase chain reaction in patients under 18 years old hospitalized due to community-acquired pneumonia (CAP) from Lima, Peru. Results: Atypical pathogens were detected in 40% (58/146); viral etiologies in 36% (52/146) and coinfections in 19% (27/146). The most common etiological agent was M. pneumoniae (n = 47), followed by C. pneumoniae (n = 11). The most frequent respiratory viruses detected were: respiratory syncytial virus A (n = 35), influenza virus C (n = 21) and parainfluenza virus (n = 10). Viral-bacterial and bacterium-bacterium coinfections were found in 27 cases. In our study population, atypical bacteria (40%) were detected as frequently as respiratory viruses (36%). The presence of M. pneumoniae and C. pneumoniae should not be underestimated as they can be commonly isolated in Peruvian children with CAP.


AUTOR : del Valle-Mendoza, Juana ( 0000-0002-6011-5040 )  ; Silva-Caso, Wilmer; Cornejo-Tapia, Angela; Orellana-Peralta, Fiorella; Verne, Eduardo; Ugarte, Claudia; Aguilar-Luis, Miguel Angel; De Lama-Odría, María del Carmen; Nazario-Fuertes, Ronald; Esquivel-Vizcarra, Mónica; Casabona-Ore, Verónica; Weilg, Pablo; del Valle, Luis J.
REVISTA: BMC Research Notes
URL: http://hdl.handle.net/10757/622481
FULL TEXT: https://goo.gl/6rcY9L





Inclusion of persons with disabilities in systems of social protection: a population-based survey and case–control study in Peru

AUTOR : Bernabe-Ortiz, Antonio ( 0000-0002-6834-1376 )  ; Diez-Canseco, Francisco; Vasquez, Alberto; Kuper, Hannah; Walsham, Matthew; Blanchet, Karl
REVISTA: BMJ Open


OBJECTIVE: This study aims to assess the needs of people with disabilities and their level of inclusion in social protection programmes. DESIGN: Population based-survey with a nested case-control study. SETTING: Morropon, a semiurban district located in Piura, northern Peru. PARTICIPANTS: For the population survey, a two-stage sampling method was undertaken using data from the most updated census available and information of each household member aged ≥5 years was collected. In the nested case-control study, only one participant, case or control, per household was included in the study. PRIMARY AND SECONDARY OUTCOME MEASURES: Disability was screened using the Washington Group short questionnaire. A case, defined as an individual aged ≥5 years with disabilities, was matched with one control without disabilities by sex and age (±5 years). Information was collected on socioeconomic status, education, health and rehabilitation and social protection participation. RESULTS: The survey included 3684 participants, 1848 (50.1%) females, mean age: 36.4 (SD: 21.7). A total of 290 participants (7.9%; 95% CI 7.0% to 8.7%) were classified as having disability. Adults with disabilities were more likely to be single (OR=3.40; 95% CI 1.54 to 7.51) and not to be working (OR=4.36; 95% CI 2.26 to 8.40), while those who did work were less likely to receive the national minimum wage (ie, 750 PEN or about US$265; p=0.007). People with disabilities were more likely to experience health problems. There was no difference between those enrolled in any social protection programme among participants with and without disabilities. CONCLUSIONS: People with disabilities were found to have higher needs for social protection, but were not more likely to be enrolled in social protection programmes. The Peruvian social protection system should consider adding disability status to selection criteria in their cash transfer programmes as well as implementing disability-specific interventions. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/



miércoles, 17 de enero de 2018

Seropositividad a Helicobacter pylori y su relación con náusea y vómitos durante las primeras 20 semanas del embarazo

AUTOR : Castillo Contreras, Ofelia; Maguiña Quispe, Jorge; Medina Morales, Bryan; Malaverry Lozano, Héctor
EDITORIAL : Sociedad Argentina de Gastroenterologia
REVISTA: Acta Gastroenterologica Latinoamericana

Existen estudios que encontraron mayor prevalencia de anticuerpos contra Helicobacter pylori (Hp) en gestantes con hiperémesis gravídica, en comparación con mujeres embarazadas asintomáticas. Objetivos. Determinar la relación entre la seropositividad a Hp y la presencia de náusea y vómitos durante las primeras 20 semanas del embarazo en gestantes de una red hospitalaria, entre marzo y diciembre de 2015. Material y métodos. Estudio de casos y controles no pareado en gestantes hasta las 20 semanas de embarazo. El índice de Rhodes para náusea y vómitos clasificó a las gestantes en casos (9-40 puntos) y en controles (8 puntos). La seropositividad a Hp fue definida como IgG ≥ 1,1 U/mL. La asociación entre Hp y náusea y vómitos del embarazo se determinó con el análisis de regresión logística, controlando por edad, paridad, edad gestacional y nivel socioeconómico. Resultados. Un total de 108 pacientes fueron incluidas, 21 controles y 87 casos. No hubo diferencias significativas en edad (p = 0,916), paridad (p = 0,18) y nivel socioeconómico (p = 0,36). La seropositividad a Hp en los casos fue 78,2% (68/87) y en los controles 61,9% (13/21). En el análisis de regresión logística, los casos presentaron mayor riesgo de seropositividad a Hp que los controles (OR = 3,05; IC 95%: 0,92-10,1; p = 0,068), pero no fue significativa. Conclusiones. Las pacientes con náusea y vómitos en las primeras 20 semanas de gestación tuvieron un mayor riesgo de haber estado expuestas a Hp, aunque esta relación no fue significativa debido al pequeño tamaño de muestra.


martes, 16 de enero de 2018

Comments on “Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors” by Parise CA and Caggiano V, Breast Cancer Res Treat, 2017.

Authors: Pichilingue-Febres, Alejandra F.Arias-Linares, Miguel A.Araujo-Castillo, Roger V.
Journal: Breast Cancer Research and Treatment


We would like to express our opinion regarding a Parise and Caggiano paper recently published in your journal. We certainly believe this is a great contribution, since it found that node-negative HER2 (+) breast cancer patients have better survival contrary to the common knowledge. This finding could reflect the consequences of targeted therapies that are changing the natural history of the disease. However, we think that such an interesting analysis could also have been done with stage III and IV patients, since this group of people could benefit greatly from these findings. In fact, new guidelines now recommend the use of HER2-specific therapy for stage IV patients with positive markers, even for life if they do not show signs of progression. Additionally, we would like to discuss the value of adding the Ki-67 marker to the classification proposed by the authors, because several papers consider it an important prognostic factor. © 2017 Springer Science+Business Media, LLC, part of Springer Nature



Full text / Texto completo:
http://repositorioacademico.upc.edu.pe/upc/retrieve/3570937/10.1007s10549-017-4620-y.pdf.jpg